Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Autorzy:
Chevallier P; Hematology Department, CHU Hotel-Dieu, Nantes, France. Berceanu A; Hematology Department, CHU, Besançon, France. Peterlin P; Hematology Department, CHU Hotel-Dieu, Nantes, France. Garnier A; Hematology Department, CHU Hotel-Dieu, Nantes, France. Le Bourgeois A; Hematology Department, CHU Hotel-Dieu, Nantes, France. ImbertBM; Virology Department, CHU Hotel-Dieu, Nantes, France. Daguindau E; Hematology Department, CHU, Besançon, France. Mahé B; Hematology Department, CHU Hotel-Dieu, Nantes, France. Dubruille V; Hematology Department, CHU Hotel-Dieu, Nantes, France. Blin N; Hematology Department, CHU Hotel-Dieu, Nantes, France. Touzeau C; Hematology Department, CHU Hotel-Dieu, Nantes, France. Gastinne T; Hematology Department, CHU Hotel-Dieu, Nantes, France. Lok A; Hematology Department, CHU Hotel-Dieu, Nantes, France. Tessoulin B; Hematology Department, CHU Hotel-Dieu, Nantes, France. Vantyghem S; Hematology Department, CHU Hotel-Dieu, Nantes, France. Desbrosses Y; Hematology Department, CHU, Besançon, France. Bressollette C; Virology Department, CHU Hotel-Dieu, Nantes, France. Duquesne A; Cellular Engineering Unit, EFS Pays de la Loire, Nantes, France. Eveillard M; Hematology/Biology Department, CHU Hotel-Dieu, Nantes, France. Le Bris Y; Hematology/Biology Department, CHU Hotel-Dieu, Nantes, France. Dormoy A; EFS Bourgogne Franche-Comté, Besançon, France. Malugani C; EFS Bourgogne Franche-Comté, Besançon, France. Deconinck E; Hematology Department, CHU, Besançon, France.; Université de Franche-Comté, Inserm UMR1098 RIGHT, Besançon, France. Moreau P; Hematology Department, CHU Hotel-Dieu, Nantes, France. Le Gouill S; Hematology Department, CHU Hotel-Dieu, Nantes, France. Béné MC; Hematology/Biology Department, CHU Hotel-Dieu, Nantes, France. Guillaume T; Hematology Department, CHU Hotel-Dieu, Nantes, France.
Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
Autorzy:
Trang-Poisson C; Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.; Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France. Kerdreux E; Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.; Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France. Poinas A; Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France. . Planche L; Methodology and Biostatistics Unit, Delegation to Clinical Research and Innovation for CHU Nantes and Vendée departmental Hospital, Nantes, La Roche sur Yon, France. Sokol H; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint Antoine, Gastroenterology & Nutrition Department, F-75012, Paris, France. Bemer P; MiHAR lab, Nantes University, 44000, Nantes, France.; Department of Emergency Medicine, CHU Nantes, Nantes, France. Cabanas K; Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.; Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France. Hivernaud E; Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.; Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France. Biron L; Sponsor Department, CHU Nantes, Nantes, France. Flet L; Pharmacy Department, CHU Nantes, Nantes, France. Montassier E; MiHAR lab, Nantes University, 44000, Nantes, France.; Department of Emergency Medicine, CHU Nantes, Nantes, France. Le Garcasson G; MiHAR lab, Nantes University, 44000, Nantes, France.; Department of Emergency Medicine, CHU Nantes, Nantes, France. Chiffoleau A; Sponsor Department, CHU Nantes, Nantes, France. Jobert A; Sponsor Department, CHU Nantes, Nantes, France. Lepelletier D; Bacteriology and Infection Control Department, CHU Nantes, 44000, Nantes, France. Caillon J; Bacteriology and Infection Control Department, CHU Nantes, 44000, Nantes, France. Le Pape P; Parasitology-Mycology Department, Institute of Biology CHU Nantes, Nantes, France. ImbertBM; Virology Department, CHU Nantes, Nantes, France. Bourreille A; Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.; Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France.
Pokaż więcej
Źródło:
Trials [Trials] 2020 Jun 03; Vol. 21 (1), pp. 455. Date of Electronic Publication: 2020 Jun 03.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
